MedPath

Third Eye Panoramic Device Feasibility Evaluation

Not Applicable
Conditions
Colorectal Neoplasms
Registration Number
NCT02368977
Lead Sponsor
Avantis Medical Systems
Brief Summary

This study will evaluate the feasibility of using the Third Eye Panoramic device in conjunction with standard colonoscopes in a clinical setting.

Patients will undergo a colonoscopy procedure during which the study device will provide video imaging of areas of the colon that are difficult to evaluate with the colonoscope alone.

The utility of the device will be assessed from the impressions of the investigators and from telephone follow-up with subjects to assess for post-procedural complications.

Detailed Description

The purpose of this study is to evaluate the feasibility of using the Third Eye Panoramic device along with a standard colonoscope as a means of enhancing the ability of endoscopists to view areas that are hidden from the view of the colonoscope.

Colonoscopy is generally agreed to be the best method for detecting and removing cancers and pre-cancerous adenomas in the colon. However, numerous studies have demonstrated that from 22% to over 40% of adenomas are missed during standard colonoscopy. More importantly, 12% of large adenomas (at least 1 cm) are missed even by expert endoscopists using meticulous technique with the best available equipment, and these large adenomas are the ones that are most likely to transform into cancer.

Factors such as quality of bowel cleansing and time spent examining the colonic mucosa have been shown to affect miss rates. However, comparison with the results of CT colonography has shown that 2/3 of missed adenomas are located behind folds in the wall of the colon, in areas that are very difficult to see with a standard forward-viewing colonoscope.

When clipped onto the tip of a standard colonoscope, the Third Eye Panoramic device provides two additional miniature video cameras and light sources that offer views to the left side and right side of the colonoscope's tip. These lateral views complement the forward view of the colonoscope's camera to result in a "panoramic" view of over 300°. This extreme wide-angle view allows the endoscopist to examine the areas located behind folds.

In this study, each subject will undergo a colonoscopy procedure utilizing the Third Eye Panoramic device along with a standard colonoscope.

The investigators will evaluate issues related to usability and safety based on their experience and impressions, with telephone follow-up with subjects to assess for any post-procedural complications.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  1. The patient is undergoing colonoscopy for screening, for surveillance in follow-up of previous polypectomy or for diagnostic workup.
  2. The patient must understand and provide written consent for the procedure.
Exclusion Criteria
  1. Patients >75 years of age;
  2. Patients with a history of colonic resection;
  3. Patients with suspected chronic stricture potentially precluding complete colonoscopy;
  4. Patients with diverticulitis or toxic megacolon;
  5. Patients with a history of radiation therapy to abdomen or pelvis;
  6. Patients who are currently enrolled in another clinical investigation in which the intervention might compromise the safety of the patient's participation in this study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Device usability factors1 hour (average duration of procedure)

Device usability as measured by investigators' qualitative impressions regarding ease of use and any potential interference with function of colonoscope.

Secondary Outcome Measures
NameTimeMethod
Device video factors1 hour (average duration of procedure)

Video image quality and ability to view areas behind folds as measured by investigators' qualitative impressions

Patient safety assessed by number of subjects with adverse events as a measure of safety and tolerabilityAt time of procedure and up to 48 hours after completion of procedure

Number of subjects with adverse events

Trial Locations

Locations (1)

New York Hospital Queens

🇺🇸

Flushing, New York, United States

New York Hospital Queens
🇺🇸Flushing, New York, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.